[Skip to content](https://oculogica.com/sisters-get-concussion-diagnostic-funded-fda-approved-and-reimbursed/#content)

CEO Rosina Samadani is featured in a story by Geri Stengel at Forbes. [Click here](https://www.forbes.com/sites/geristengel/2022/12/07/sisters-get-concussion-diagnostic-funded-fda-approved-and-reimbursed/?sh=70ea2f771b01) to read the full

article.

Two sisters teamed up to develop and bring to market an EyeBOX—the first

objective diagnostic for concussions. The algorithm-based test takes less than four

minutes, is non-invasive, and can be used with children and adults. Oculogica’s

EyeBOX moves beyond the subjective “follow my finger” to an objective technology

that diagnoses concussions accurately.

Experience, relationships, diplomacy, and perseverance helped the pair jump over

the typical hurdles of funding, FDA clearance, and payer reimbursement that a

medical device must navigate to be a success.

he first version of the product was brought to market in 2019 and a portable, user-

friendly device launched in March of 2022. “We just installed it at the Mayo Clinic,

which is a very big deal,” said Rosina. “It’s considered the number one clinic in the

country, and we’re extremely excited about that.”

Other institutions, such as Midwest Orthopaedics at Rush, a top-10 orthopedic

hospital in the country, Children’s Hospital of Philadelphia, the University of

Colorado, and the Minneapolis Clinic of Neurology are using the device, too.

Oculogica will be launching a product for a second indication to measure impairment

due to cannabis. Since the product is intended for use by law enforcement and not

medical providers, it does not need to go through FDA clearance and get CPT

categorization.

### Leave a Comment [Cancel Reply](https://oculogica.com/sisters-get-concussion-diagnostic-funded-fda-approved-and-reimbursed/\#respond)

Your email address will not be published.Required fields are marked \*

Type here..

Name\*

Email\*

Website

Save my name, email, and website in this browser for the next time I comment.

Δ

Scroll to Top